Is Voltaren (diclofenac) contraindicated for shoulder pain?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 11, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Is Voltaren (Diclofenac) Contraindicated for Shoulder Pain?

No, Voltaren (diclofenac) is not contraindicated for shoulder pain, but it has not been formally evaluated for shoulder use and carries important cardiovascular and gastrointestinal risks that require careful patient selection.

FDA-Approved Indications and Limitations

The FDA label for topical Voltaren Gel specifically states it is "indicated for the relief of the pain of osteoarthritis of joints amenable to topical treatment, such as the knees and those of the hands" but explicitly notes that "Voltaren Gel has not been evaluated for use on the spine, hip, or shoulder" 1. This does not constitute a contraindication—rather, it reflects a lack of formal evaluation in shoulder joints.

Actual Contraindications for Voltaren

The true contraindications for diclofenac are 1:

  • Known hypersensitivity to diclofenac
  • History of asthma, urticaria, or allergic reactions to aspirin or other NSAIDs
  • Treatment of perioperative pain in coronary artery bypass graft (CABG) surgery setting

Clinical Evidence Supporting Use in Shoulder Pain

Despite the lack of FDA evaluation for shoulder use, multiple clinical trials demonstrate diclofenac's efficacy for shoulder conditions:

  • Periarthritis of the shoulder: Diclofenac 50mg three times daily showed equivalent efficacy to oxaprozin in reducing shoulder pain scores, with good tolerability 2
  • Acute tendinitis/bursitis: Diclofenac demonstrated similar improvements to combination therapy in physician and patient assessments over 14 days 3
  • Painful stiff shoulder: Diclofenac 50mg three times daily produced pain relief and improved range of motion comparable to ibuprofen 4, 5, 6
  • Intra-articular formulation: Diclofenac-hyaluronate conjugate showed no statistically significant benefit over placebo for shoulder OA specifically (group difference 0.15,95% CI -0.48 to 0.78) 7

Guideline Recommendations for Shoulder Pain Management

The Canadian Stroke Best Practice Recommendations explicitly state: "If there are no contraindications, analgesics (such as acetaminophen or ibuprofen) can be used for pain relief" in hemiplegic shoulder pain 8. While this guideline addresses post-stroke shoulder pain specifically, it establishes that NSAIDs like diclofenac are appropriate when contraindications are absent.

Critical Safety Considerations

Cardiovascular Risks

NSAIDs including diclofenac "may cause an increased risk of serious cardiovascular thrombotic events, myocardial infarction, and stroke, which can be fatal" 1. A 2007 American Heart Association statement showed diclofenac carried elevated cardiovascular risk with a relative risk of 1.63 (95% CI 1.12-2.37) for vascular events compared to placebo 9.

Absolute Contraindications for Systemic NSAIDs

Based on geriatric pain management guidelines, NSAIDs should be avoided in 10:

  • Current active peptic ulcer disease
  • Chronic kidney disease
  • Heart failure

Relative Contraindications Requiring Caution

  • Hypertension
  • History of peptic ulcer disease or Helicobacter pylori
  • Concomitant use of corticosteroids or SSRIs 10
  • Advanced age (elderly patients at greater risk for serious GI events) 1

Practical Clinical Algorithm

For shoulder pain management with diclofenac:

  1. Screen for absolute contraindications (hypersensitivity, active PUD, CKD, heart failure, perioperative CABG setting) 10, 1

  2. Assess cardiovascular risk factors - patients with established CVD or multiple risk factors face higher risk with any NSAID use 9, 1

  3. Consider topical formulation first when feasible, as topical diclofenac demonstrates efficacy for musculoskeletal pain with lower systemic absorption and better safety profile than oral NSAIDs 11, 12, 13

  4. Use lowest effective dose for shortest duration - risks increase with higher dosages and longer use 14

  5. Add gastroprotection with proton pump inhibitor or misoprostol if systemic NSAID is necessary 10

  6. Monitor regularly for GI toxicity, renal function, blood pressure, and heart failure symptoms 10

Alternative Approaches

For shoulder pain when NSAIDs are contraindicated or high-risk 14, 15:

  • Acetaminophen as first-line (up to 4g daily, avoiding in liver failure)
  • Topical NSAIDs (better safety profile than systemic)
  • Physical therapy and range of motion exercises
  • Corticosteroid injections for inflammatory conditions
  • Duloxetine for chronic pain with neuropathic features

Common Pitfalls to Avoid

  • Do not assume "topical = safe" - topical diclofenac still carries the FDA black box warning for cardiovascular and GI risks, though systemic absorption is lower 1
  • Do not combine multiple NSAIDs - patients should not take more than one NSAID simultaneously 10
  • Do not ignore the lack of shoulder-specific data - while off-label use is supported by clinical trials, formal FDA evaluation for shoulder joints is absent 1
  • Do not use in elderly without careful risk-benefit assessment - older patients face substantially higher risks of serious adverse events 10, 1

References

Research

Treatment of periarthritis of the shoulder: a comparison of ibuprofen and diclofenac.

The Journal of international medical research, 1984

Research

Diclofenac sodium in the treatment of painful stiff shoulder.

Current medical research and opinion, 1983

Guideline

pharmacological management of persistent pain in older persons.

Journal of the American Geriatrics Society (JAGS), 2009

Guideline

adult cancer pain.

Journal of the National Comprehensive Cancer Network : JNCCN, 2010

Guideline

polypharmacy management in older patients.

Mayo Clinic Proceedings, 2021

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.